Alan Peigh

Alan Peigh serves as a key procurement professional within the National Cancer Institute, supporting the agency’s mission to accelerate cancer research through advanced scientific infrastructure and diagnostic technologies. He manages complex acquisitions for high-performance computing services, bioinformatics platforms, and data analytics systems critical to genomic research and precision oncology initiatives. His work ensures that NCI’s scientific community has access to cutting-edge computational tools and cloud-enabled research environments, aligning procurement strategy with the institute’s translational research priorities. Peigh specializes in non-personal services contracts under the Other Computer Related Services category, frequently engaging vendors to deliver scalable, secure, and compliant data management solutions. His primary contractor relationships center on Roche Diagnostics Corporation, with whom he collaborates on integrated diagnostic platforms, laboratory information systems, and AI-driven analytics tools that support large-scale cancer genomics initiatives. These partnerships reflect a focus on industry leaders with proven capabilities in clinical data integration, molecular diagnostics, and regulatory-compliant software deployment. Peigh’s procurement approach emphasizes performance-based outcomes, vendor technical maturity, and seamless interoperability with NCI’s existing research ecosystems. Peigh’s contracting activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic alignment with NCI’s need for specialized, high-capability vendors capable of delivering mission-critical technologies at scale, where only a limited pool of qualified contractors meets technical and compliance requirements. His procurement focus is exclusively on NAICS 541519—Other Computer Related Services—encompassing bioinformatics consulting, high-throughput data processing, machine learning model development, and secure cloud-based research infrastructure. He routinely acquires services that enable genomic sequencing analysis, tumor profiling, and real-time data sharing across multi-institutional research networks, underscoring deep expertise in computational biology and health data interoperability.